ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

TRVN Trevena Inc

0.40
-0.0043 (-1.06%)
Jun 07 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 75,297
Bid Price 0.38
Ask Price 0.4069
News -
Day High 0.412

Low
0.3001

52 Week Range

High
1.12

Day Low 0.38265
Company Name Stock Ticker Symbol Market Type
Trevena Inc TRVN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0043 -1.06% 0.40 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.412 0.38265 0.412 0.3996 0.4043
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
199 75,297 $ 0.3921235 $ 29,526 - 0.3001 - 1.12
Last Trade Time Type Quantity Stock Price Currency
17:00:02 formt 200 $ 0.40 USD

Trevena Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
7.33M 18.32M - 3.13M -40.29M -2.20 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Trevena News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No TRVN Message Board. Create One! See More Posts on TRVN Message Board See More Message Board Posts

Historical TRVN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.3920.43690.382650.406292245,4300.0082.04%
1 Month0.42890.43970.380.407573950,179-0.0289-6.74%
3 Months0.560.5680.30010.4074868182,458-0.16-28.57%
6 Months0.630.76930.30010.4971712144,429-0.23-36.51%
1 Year1.041.120.30010.7710569322,796-0.64-61.54%
3 Years45.7555.000.300114.351,037,615-45.35-99.13%
5 Years26.50112.500.300140.041,909,999-26.10-98.49%

Trevena Description

Trevena Inc is an American biotechnology company. The portfolio pipeline is focused on medicines targeting pain management: TRV734: oral medicine for moderate to severe pain; TRV250: oral medicine for migraines; and TRV027: treatment for acute heart failure. Its leading product is oliceridine (TRV130), a protein-based chemical meant to manage moderate to severe acute pain.